Last updated on January 2020

A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for IMISC


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Psoriasis | Hidradenitis Suppurativa | Hand Dermatitis | Alopecia | ATOPIC DERMATITIS | Atopic | Eczema (Atopic Dermatitis) | Vitiligo | Dermatitis | Hair Loss | Psoriasis and Psoriatic Disorders | Acne Inversa | Eczma (Dermatite Atopique) | Male Pattern Baldness | Dermatite Atopique
  • Age: - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • 1. Adults and children (all ages) with Atopic Dermatitis or other Immune-mediated Inflammatory Skin Conditions been prescribed any dermatologic treatment.
  • 2. Participant has plans for future visits at the site for continued management of IMISC.

Exclusion Criteria:

  • 1. Inability to provide written informed consent/assent.
  • 2. Subjects participating in any interventional study or trial for IMISC treatment trial at the time of enrollment. Patients may be enrolled in TARGET-DERM once participation in the trial is complete. Note: Participants may be enrolled in other registries or studies where IMISC treatment outcomes are observed and/or reported (such as center-based registries).

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.